Summary of Purpose
"Left Atrial Appendage Occlusion and Biomarker Evaluation" (LABEL) is a single-center, prospective and observational study evaluating changes of the expression of biomarkers in eligible patients before and after percutaneous implantation of a left atrial appendage (LAA) occlusion device at mid-term follow-up.Read More →
The following dates are available for this trial. Trial information last updated on 7 December 2016.
|1 Jun 2014||3 Dec 2016||1 Dec 2020||Unavailable||1 Dec 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|